Top Markets
#1 DogBull DogBull +108.52%
#2 MarsCoin MarsCoin +77.08%
#3 Siacoin Siacoin +54.30%
#4 ADO Protocol ADO Protocol +52.57%
#5 The Bitcoin Bull The Bitcoin Bull +28.16%
#6 Ontology Gas Ontology Gas +25.60%
#7 Apertum Apertum +16.37%
#8 Pons Pons +14.02%
#9 Useless Coin Useless Coin +13.13%
#10 Arowana Arowana +12.73%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Lexeo Therapeutics, Inc. Common Stock Lexeo Therapeutics, Inc. Common Stock

Lexeo Therapeutics, Inc. Common Stock

LXEO
Clasificación en acciones #15117
Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical... Lexeo Therapeutics, Inc. is a genetic medicine firm currently in the clinical development phase, dedicated to addressing both inherited and acquired medical conditions. Its robust pipeline features several gene therapy candidates. These include LX2006, an AAVrh10-based therapy aimed at treating cardiomyopathy linked to Friedreich's ataxia (FA); LX2020, another AAVrh10-based candidate targeting arrhythmogenic cardiomyopathy; LX2021, designed for DSP cardiomyopathy; and LX2022, which focuses on hypertrophic cardiomyopathy (HCM) stemming from TNNI3 mutations. Furthermore, Lexeo is advancing LX1001, an AAVrh10-based gene therapy, alongside LX1020 and LX1021, all intended for individuals homozygous for APOE4. Additionally, LX1004 is under development to treat CLN2 Batten disease. Established in 2017, the company's headquarters are located in New York, New York.
Precio por acción
$4.74
Última sincronización: 2026-08-31
Capitalización bursátil
$372.19M
Cambio (1 día)
-2.47%
Cambio (1 año)
-1.04%
País
US
Comercio Lexeo Therapeutics, Inc. Common Stock (LXEO)

Categoría

Healthcare
Ganancias de Lexeo Therapeutics, Inc. Common Stock (LXEO)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Lexeo Therapeutics, Inc. Common Stock, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Lexeo Therapeutics, Inc. Common Stock desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH